Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development.
Authors
Wan Ying Tan
Yale University, New Haven, CT;
Wan Ying Tan , Melissa Tian , Nensi Ruzgar , Astrid Hengartner , Bethsebie Sailo , Olivia Ang-Olson , Airol Ubas , Nithyla John , Vesal Yaghoobi , Haoyu Tang , Anup Sharma , ILKe Nalbantoglu , Nita Ahuja
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 189)
DOI
10.1200/JCO.2023.41.4_suppl.189
Abstract #
189
Poster Bd #
K11
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Putative biomarkers of response to anti-PD-1 therapy in metastatic castration-resistant prostate cancer (mCRPC).
First Author: Khobe Chandran
Poster
2024 ASCO Genitourinary Cancers Symposium
Comprehensive analysis of targetable alterations in urachal cancer by NGS.
First Author: David Joseph Benjamin
Poster
2020 ASCO Virtual Scientific Program
Genomic landscape and immune phenotype of malignant pleural mesothelioma.
First Author: Meera Patel
Poster
2019 ASCO Annual Meeting
IL2-STAT5 immune signatures to predict responses to PD-1 inhibition and azacitidine treatment in acute myeloid leukemia (AML): A subset analysis of a phase 2 study.
First Author: Hussein Abbas